ClinicalTrials.govpublic full text
Phase I Study of RNA Oligonucleotide, MTL-CEBPA, Atezolizumab and Bevacizumab in Patients With Advanced Hepatocellular Carcinoma.
advanced hepatocellular carcinoma, mtl-cebpa, atezolizumab, bevacizumab, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 869309
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.